Clinical Research Directory
Browse clinical research sites, groups, and studies.
Proteolytic Enzyme Fortified Protein Supplement in Chronic Pancreatitis.
Sponsor: Asian Institute of Gastroenterology, India
Summary
A complex disease, Chronic Pancreatitis (CP) is caused by a wide range of factors, including smoking, alcoholism, autoimmune disorders, and obstruction of the major pancreatic duct. In patients who are genetically susceptible to the condition, these factors can result in damage to the acinar, ductal, and islet cells, as well as persistent inflammatory infiltration and fibrosis. Malnutrition is an ongoing concern for persons with CP, even though pain is the primary symptom in most cases. Complications that commonly arise during the disease's natural history include exocrine and endocrine pancreatic insufficiency and local changes (such as pseudocyst, biliary and duodenal blockage, splenic and portal vein thrombosis, and pancreatic cancer). Consequently, CP mortality is higher than that of the general population.
Official title: Impact of Proteolytic Enzyme Fortified Protein Supplement in Patients With Chronic Pancreatitis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-09-01
Completion Date
2025-06-30
Last Updated
2024-09-05
Healthy Volunteers
No
Conditions
Interventions
Proteolytic enzyme fortified protein supplement
Group I receive Enzotein 15 gms (proteolytic enzyme with 70000 Hb unit tyrosine (HUT) fortified with 15 gms of whey protein), given for 6 weeks. Enzotein will be provided by (Mylin Biotech India Ltd.)
Locations (1)
Asian Institute of Gastroenterology Hospitals
Hyderabad, Telangana, India